Learn More
Medchemexpress LLC Tasurgratinib succinate | 1879965-80-6 | 99.2% | 764.82 g/mol | C32H37N5O6·3/2 C4H6O4 | 25 MG

Supplier: Medchemexpress LLC HY101466A25MG
Tasurgratinib succinate is an orally available, selective small-molecule inhibitor of fibroblast growth factor receptors FGFR1, FGFR2, and FGFR3. Supplied as the succinate salt for research use, the compound is characterized by a defined molecular formula and high purity for preclinical and translational studies probing FGFR-driven signaling and anticancer activity.
- Selective FGFR1-3 inhibition with low nanomolar potency.
- High reported purity suitable for research applications.
- Supplied as a succinate salt for improved stability and handling.
- Molecular weight and formula provided for analytical characterization.
- Soluble in common organic solvents for in vitro testing.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.